Navigation Links
CNIO researchers identify a new gene that is essential for nuclear reprogramming
Date:6/5/2013

Researchers are still fascinated by the idea of the possibility of reprogramming the cells of any tissue, turning them into cells with the capacity to differentiate into cells of a completely different type pluripotent cellsand they are still striving to understand how it happens.

A group from the Spanish National Cancer Research Centre (CNIO), headed by researcher Ralph P. Schneider, from the Telomeres and Telomerase Group led by María A. Blasco, publishes this week an article in Nature Communications on the discovery of a new gene called TRF1 that is essential for nuclear reprogramming.

It is also known that TRF1 is indispensable for protecting telomeres, the ends of chromosomes. Existing evidence suggests that the length of telomeres and pluripotencythe capacity of a cell to differentiate into multiple cell typesare related. Pluripotent cells, for example, have very long telomeresa previous finding at CNIObut until now no protective protein for the telomeres had been found that was essential for pluripotency.

To investigate the connection between telomeres and pluripotency, researchers generated a 'reporter' mouse: they linked together the TRF1 gene and the gene coding for a green fluorescent protein and created a lineage of mice carrying this new genetic baggage. In these animals, the green fluorescent protein acts as a label to show expression of TRF1.

They discovered that TRF1 is an excellent marker for stem cells, both in adult stem cellsthose that are found in tissues and the different organs of the bodyand embryonic stem cells. It is also the case with 'induced pluripotent' stem cells (iPS cells), which are pluripotent cells that come from artificially reprogrammed specialised cells.

In the case of tissues, the authors write: "TRF1 distinguishes adult stem cells and is indispensable for their functioning". The discovery is useful for both identifying and eventually isolating the stem cell population in tissues, something that is important for the development of regenerative medicine. The cells in which TRF1 is expressed are also the most pluripotent.

In iPS cells, the same thing happens. The authors explain that: "The expression of TRF1 is an indicator of pluripotency. Those iPS cells that express the highest levels of TRF1 are also the most pluripotent. Furthermore, we demonstrate that TRF1 is necessary for the induction and maintenance of pluripotency, inhibiting the triggering of DNA damage responses and apoptosis ('cell suicide')".


'/>"/>

Contact: Press Office
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related biology news :

1. Researchers develop a faster method to identify Salmonella strains
2. Researchers document acceleration of ocean denitrification during deglaciation
3. Researchers design sensitive new microphone modeled on fly ear
4. Researchers help threatened wheat crops in Asia, Africa
5. U of A medical researchers ID genetic marker for sporadic breast cancer
6. UCI researchers find sea anemone venom-derived compound effective in anti-obesity studies
7. MU researchers develop radioactive nanoparticles that target cancer cells
8. Genetic predictors of postpartum depression uncovered by Hopkins researchers
9. U of M researchers develop model for better testing, targeting of MPNST
10. Widespread but neglected disease a health threat in Africa, Virginia Tech researchers say
11. Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 The American Botanical Council ... of arnica ( Arnica montana ) through ABC,s ... HerbMedPro database, a comprehensive, interactive online ... clinical research data on the uses and health ... Naturopathica, a wellness company with healing arts ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 1, 2016 asking the Federal Drug Administration (FDA) to consider OA as a ... OARSI is concerned about the growing population of OA patients, many of whom ...
(Date:12/6/2016)... Collins, Colorado (PRWEB) , ... December 06, 2016 ... ... of dynamic aqueous plasma technology platforms, announced today that the company has engaged ... Master Research and Development Agreement (MRDA) with the CSU Office of the Vice ...
(Date:12/6/2016)... , Dec. 6, 2016  Creative Medical Technology ... , MD, PhD, FANA, FAAN to the Company,s Scientific ... and clinical trials to assist the Company,s clinical development ... AmnioStem product is a universal donor stem cell derived ... in animal models of stroke 1 .  ...
Breaking Biology Technology: